HIV/AIDS
Studies from University of California in the area of HIV/AIDS published
Published in AIDS Weekly, July 21st, 2008
"Understanding the molecular basis and evaluating the potency of an inhibitor to combat resistance are no doubt important in AIDS therapy. In this study, we first identified residues that have significant contributions to binding with six substrates using molecular dynamics simulations and Molecular Mechanics Generalized Born Surface Area calculations. Among the critical residues, Asp25, Gly27, Ala28, Asp29, and Gly49 are well conserved,...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2008-07-21)
More Articles from AIDS Weekly
- Gene Therapy
Scientists paint viruses to track their fate in the body - HIV/AIDS Co-Infection
Research from T. Bicanic and co-authors yields new data on HIV/AIDS co-infection - HIV/AIDS Co-Infection
Research results from B. Longo and co-authors update knowledge of HIV/AIDS co-infection - HIV/AIDS Co-Infection
Researchers at National Center for HIV, STD, and TB Prevention target HIV/AIDS co-infection - HIV/AIDS Co-Infection
Researchers from University of Washington report on findings in HIV/AIDS co-infection - HIV/AIDS Co-Infection
Studies from L.V. Torian and colleagues yield new information about HIV/AIDS co-infection - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
